What is XAIR's market cap?

$2.28M, based on the Nov 3 close of $2.32.

Does Beyond Air pay a dividend?

No regular cash dividend has been paid in the last year.

How much of XAIR is sold short?

59.7K shares, 6.9% of float, as of Oct 15, 2026.

What sector is XAIR in?

Healthcare, in the Surgical Instruments industry.

NASDAQ · XAIRHealthcareSurgical Instruments

Beyond Air, Inc. Common Stock (XAIR)

$2.32+4.98%

Close Nov 3, 2026 · split-adjusted

Nov 3, 2026$2.24▼ 94.26% in range

Nov 3, 2025Low $2.09 · High $166.80Nov 3, 2026

What changed · written from our data

As of Nov 3, 2026

Beyond Air closed at $2.32 on Nov 3, up 4.98%, 98.6% below its 52-week closing high. Volume of 19.1K shares was 0.63× its 20-day average (below normal).

Split-adjusted performance: -18.3% over one month, -80.0% over six months, -94.4% over one year.

In the quarter ended Jun 30, 2026, revenue was $1.77M, up 0.5% from a year earlier, with a net margin of -448.8%.

Short interest was 59.7K shares at the Oct 15 settlement, down 4.9% from the prior report (6.9% of float, 1.3 days to cover).

Market cap$2.3M984.4K shares

Revenue · quarter$1.8M+0.5% YoY

Diluted EPS$-11.00—

P/E · TTM—P/S 0.3×

Net margin-448.8%Gross 12.7%

Dividend yieldNone

52-week range2.09 – 166.80−98.6% from high

Volume19.1K0.63× 20-day avg

Volatility · 60d103.3%Annualised

Short % of float6.9%1.3 days to cover

Net cash-$12.6MCash $9.8M

Next earnings—Not scheduled

Split-adjusted performance

1W +5.0%1M −18.3%3M −59.2%6M −80.0%YTD −84.0%1Y −94.4%3Y −99.7%5Y −99.9%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum7

Revenue growth23

Net margin10

Value (low P/E)—

Size5

Industry medians: 6-month return −9.7%, revenue growth +8.9%, net margin −8.2%, P/E 28.1×.

Short interest

Details →

Shares short59.7K−4.9% vs prior

Days to cover1.3Settled Oct 15

% of float6.9%

Short vol. 10d65.1%of daily volume

Closest peers by size in Surgical Instruments

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
XAIRBeyond Air	$2.32	+4.98%	−80.0%	+0.5%	−448.8%	—	$2.3M
IVFINVO Fertility	$1.94	+6.01%	−74.3%	+16.7%	40.9%	—	$2.2M	Compare
VVOSVivos Therapeutics	$0.1098	+1.39%	−84.5%	+34.9%	−106.4%	—	$2.2M	Compare
ADGMAdagio Medical Holdings	$0.0862	−0.92%	−91.2%	—	—	—	$2.4M	Compare
NXGLNexGel	$4.48	+18.21%	−62.1%	+27.8%	−98.6%	—	$2.2M	Compare
BJDXBluejay Diagnostics	$2.21	−73.94%	−71.4%	—	—	—	$2.5M	Compare
AMIXAutonomix Medical	$1.66	−1.19%	−79.1%	—	—	—	$3.3M	Compare
CODXCo-Diagnostics	$0.3800	+7.56%	—	+2.0%	−3782.4%	—	$3.4M	Compare
AEMDAETHLON MEDICAL	$5.80	+9.64%	−50.8%	—	—	—	$4.1M	Compare

News about Beyond Air

All news →

Beyond Air (XAIR) Q4 2026 Earnings Call TranscriptThe Motley Fool · Jun 27, 2026▲ Positive Beyond Air, Inc. Urges Stockholders to Vote “FOR” All Proposals Ahead of the Upcoming Special MeetingGlobeNewswire Inc. · Jun 10, 2026▼ Negative Beyond Cancer Reports Updated Survival and Safety Data from Phase 1 UNO Trial Presented at AACR 2026GlobeNewswire Inc. · Apr 20, 2026▲ Positive Beyond Air to Participate in the 38th Annual Roth Conference in MarchGlobeNewswire Inc. · Mar 11, 2026Neutral

Quick answers

What does Beyond Air do?: Beyond Air Inc a commercial-stage medical device and biopharmaceutical company developing a platform of nitric oxide (NO) generators and delivery systems (the LungFit platform) capable of generating NO from ambient air. Its segments are Beyond Air, Beyond Cancer, and NeuroNos.
What is XAIR's market cap?: $2.28M, based on the Nov 3 close of $2.32.
Does Beyond Air pay a dividend?: No regular cash dividend has been paid in the last year.
How much of XAIR is sold short?: 59.7K shares, 6.9% of float, as of Oct 15, 2026.
What sector is XAIR in?: Healthcare, in the Surgical Instruments industry.

About Beyond Air

Beyond Air Inc a commercial-stage medical device and biopharmaceutical company developing a platform of nitric oxide (NO) generators and delivery systems (the LungFit platform) capable of generating NO from ambient air. Its segments are Beyond Air, Beyond Cancer, and NeuroNos. The company generates majority of revenue from Beyond Air. It has developed the Beyond Air NO generator and delivery system which it call LungFit, a novel and precise delivery system that uses NO generated from ambient air with a novel NO generator, the ionizer. Its product and technology includes LungFitPH.

HQ: Garden City, NY54 employeesListed Apr 27, 2016beyondair.net

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology